Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Inherit Metab Dis ; 27(2): 229-40, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15159654

RESUMO

We report the clinical and radiological central nervous system (CNS) findings of 8 Fabry disease patients, before (8/8) and after (7/8) 12 months of enzyme replacement therapy (ERT) with agalsidase-alpha. Eight biochemically proven Fabry disease patients (from four families) were included. Patients were evaluated at baseline and at regular intervals during 12 months of ERT. Evaluations included a thorough, standardized neurological examination, and magnetic resonance imaging (MRI) and angiography (MRA). Brain proton magnetic resonance spectroscopy (MRS) was also performed in 5/8 patients. The presence and location of grey- and white-matter lesions, the presence of vascular occlusion or ectasia on MRA and the metabolite ratios on MRS were determined, as well as their relation to age, symptoms and neurological examination. Neurological examination showed few abnormalities in these patients: scores varied (on a 0-100 scale) from zero to 5, at baseline and in the 12th month of ERT. The most consistent findings on MRI were asymmetric, widespread patterns of deep white-matter (WM) lesions, hyperintense on T2 and FLAIR-weighted images, found in 4/8 patients at baseline, predominantly in frontal and parietal lobes. These lesions did not correlate with other clinical variables, although there was a trend towards an association of the lesions with age and hearing loss. The youngest patient with MRI lesions was 24 years old. After 12 months of ERT, MRI was normal in 3/7, showed the same WM lesions in 2/7, and showed worsening of WM lesions in 2/7 patients (from the same family). Abnormal MRS metabolite ratios were detected at baseline in 4/5 patients. While neurological examination remained almost normal during the 12 months of ERT, new small-vessel CNS involvement still appeared in 2/7 patients. We do not know why ERT was not able to prevent this in these two related male patients. This could be due either to their older ages (46 and 36 years), or to a more pathogenic mutation. We conclude that MRI was more sensitive than neurological examination in detecting CNS involvement and progression in Fabry disease in the time interval studied.


Assuntos
Encéfalo/patologia , Doença de Fabry/tratamento farmacológico , Doença de Fabry/patologia , Isoenzimas/administração & dosagem , Imageamento por Ressonância Magnética , alfa-Galactosidase/administração & dosagem , Adulto , Estudos de Coortes , Progressão da Doença , Feminino , Seguimentos , Humanos , Espectroscopia de Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Exame Neurológico , Sensibilidade e Especificidade
2.
Surg Neurol ; 38(5): 338-40, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1485209

RESUMO

Synovial cysts are not an uncommon feature in the mobile spinal segments. The lack of reports at the thoracic level has stimulated us to present this patient with compression of the 10th dorsal root.


Assuntos
Síndromes de Compressão Nervosa/etiologia , Doenças da Coluna Vertebral/diagnóstico , Raízes Nervosas Espinhais , Cisto Sinovial/diagnóstico , Nervos Torácicos , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Doenças da Coluna Vertebral/complicações , Cisto Sinovial/complicações , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...